Injective

DeFi

Cosmos

Celestia

<p><a href="https://www.thecoinrepublic.com/2023/11/17/cosmos-atom-enlisted-relief-rally-is-it-a-value-pick-for-2025/" target="_blank" rel="noopener noreferrer nofollow">Cosmos (ATOM)</a>-linked blockchains are among the early gainers of 2024, as Injective (INJ) and Celestia (TIA) surge to all-time highs. While they remain good value to make gains throughout the year, the truth is that both Injective and Celestia have already mooned, with both projects’ market caps surging past the billion-dollar mark as of February.</p>
<p>There is still plenty of money to be made in undervalued small-caps and presale gems, and these opportunities could generate an easy 20x to even 100x. Thus far, one of the hottest presales has emerged in the DeFi sector this year in the form of <a href="http://kelexo.com" target="_blank" rel="noopener noreferrer nofollow">Kelexo (KLXO)</a>.</p>
<h2 class="wp-block-heading" id="strong-the-lowdown-on-injective-inj-price-analysis-strong"><strong>The Lowdown on Injective (INJ): Price Analysis</strong></h2>
<p>Injective (INJ) is a Cosmos SDK-based blockchain that provides decentralized order book modules to help developers build DeFi apps. As of February 14th, INJ was trading 23.1% below its January 2024 all-time highs of $45, or $34.50 at press time. Injective (INJ) has largely cooled off its hot run from Q4 2023 until the beginning of 2024, with token prices down 16% in the past month.</p>
<h2 class="wp-block-heading" id="strong-the-lowdown-on-celestia-tia-price-analysis-strong"><strong>The Lowdown on Celestia (TIA): Price Analysis</strong></h2>
<p><a href="https://www.thecoinrepublic.com/2024/02/05/celestia-early-backers-move-from-ethereum-classic-to-deestream-dst-presale/" target="_blank" rel="noopener noreferrer nofollow">Celestia (TIA) </a>is another Cosmos-native blockchain renowned for its support of modular blockchain architecture that has seen its native token surge recently. TIA started 2024 priced around the $13 range until it peaked last February 10th at $20.85. Celestia (TIA) is currently undergoing a correction, trading at $19 as of February 14th. Nevertheless, Celestia (TIA) is still up 16% in the past 14 days, although its $3.1 billion market cap limits its future growth to around 2x or 3x for the rest of the year.</p>
<h2 class="wp-block-heading" id="strong-kelexo-klxo-banking-on-the-defi-renaissance-strong"><strong>Kelexo (KLXO) Banking on the DeFi Renaissance</strong></h2>
<p>One recently launched <a href="https://www.thecoinrepublic.com/2023/06/18/defi-protocol-eigenlayer-a-restaking-collective-for-ethereum/" target="_blank" rel="noopener noreferrer nofollow">DeFi protocol </a>is set to elevate the P2P lending industry with its innovative decentralized marketplace offering: <a href="http://kelexo.com" target="_blank" rel="noopener noreferrer nofollow">Kelexo (KLXO)</a>. DeFi’s decentralized P2P lending marketplace is designed to attract new users and audiences by simplifying the lending process and making it as easy as shopping on Amazon or eBay—except for crypto-backed loans. Kelexo (KLXO) will be the first no-KYC, automated, decentralized lending marketplace driven by immutable, audited, and secure smart contracts.</p>
<p>KLXO is launching its KLXO token at a low entry price of just $0.022 during stage 1. Market analysts predict that the token could turn in a potential 20x in 2024. Industry observers predict KLXO to trade within the $0.40 to $1 range, indicating a potential 20x to 50x within the next 12 months.</p>
<p>DeFi is coming back in a big way in 2024, and Kelexo is expected to be a major fulcrum in spurring this resurgence. Do not miss out on a blue chip and join the Kelexo (KLXO) <a href="https://presale.kelexo.com/login" target="_blank" rel="noopener noreferrer nofollow">presale</a> today.</p>
<h4 class="wp-block-heading"><strong>Find out more about the Kelexo (KLXO) presale by visiting the website </strong><a href="https://kelexo.com" target="_blank" rel="noopener noreferrer nofollow"><strong>here</strong></a></h4>
<p><strong>Disclaimer:</strong> Any information written in this press release or sponsored post does not constitute investment advice. Thecoinrepublic.com and all its authors do not, and will not endorse any information on any company or individual on this page. Readers are encouraged to do their research and take any actions based on their findings and not from any content written in this press release or sponsored post. Thecoinrepublic.com and all its authors do not and will not be responsible for any damage or loss caused directly or indirectly by the use of any content, product, or service mentioned in this press release or sponsored post.</p>

Injective & Celestia Make Huge Gains; Kelexo Presale Takes off with 20x Rumors

Table of Contents

Thecoinrepublic.com

Other articles published on Feb 16, 2024

Daily News on $LINK, $APT, $APE and Other Cryptos – Report

Best Meme Coins in 2024 – A List of The Top Rising Viral Cryptocurrencies

XCAD founder defends YouTuber KSI against pump and dump allegations

XRP Whale Transactions Stir Market Curiosity

Ethereum Futures Interest Surges on Major Exchanges

OpenAI Launches Sora, the Advanced AI for Crafting Videos from Text

Join our free newsletter for daily crypto updates!